France's AP-HP says Roche's Actemra limits need for ICU in COVID-19 patients – Reuters

France’s AP-HP says Roche’s Actemra limits need for ICU in COVID-19 patients – Reuters

A drug that fights inflammation made by Switzerland’s Roche limits the need for a transfer to intensive care units for patients suffering from moderate to severe COVID-19 related pneumonia, Paris hospitals group AP-HP said on Wednesday.

Read More…

You May Also Like